Sichuan baili pharmaceutical co
WebWe have a robust and sustainable pipeline with 5 clinical stage assets (EMB-01, EMB-02 , EMB-06 , EMB-07 and EMB-09) and more than 10 preclinical stage candidates. Our … WebOct 8, 2024 · Sichuan Baili Pharmaceutical Co., Ltd. Collaborator. SystImmune Inc. Provider of Information About this Clinical Study Sponsor; Overall Official(s) Li Zhang, Principal …
Sichuan baili pharmaceutical co
Did you know?
WebAug 25, 2024 · Sichuan Baili Pharmaceutical Co., Ltd. ClinicalTrials.gov Identifier: NCT05020457 Other Study ID Numbers: SI-B001_201 : First Posted: August 25, 2024 Key … Web在中国,公司以百利药业< Baili Pharm>/百利多特生物< Baili-Bio>为依托,负责领先化学药物及生物药物的研发。. 聚焦恶性肿瘤,研发有突破性疗效的创新型抗体药物及ADC药物。. …
WebSichuan Baili Pharmaceutical Co Ltd: Solid tumours; Hematologic Neoplasms; Glioma; Neoplasm Metastasis: Details: IMB-071703: IMB071703; IMB-071703: Phase 1 Clinical: Beijng Immunoah Pharma Tech Co Ltd: Solid tumours: Details: Humanized CART Directed Against BCMA: ARI-0002h: Phase 2 Clinical: Instituto De Salud Carlos Iii: WebApr 7, 2024 · Sichuan Baili Pharmaceutical Co., Ltd. Information provided by (Responsible Party): Sichuan Baili Pharmaceutical Co., Ltd. Study Details; Tabular View; No Results Posted; Disclaimer; How to Read a Study Record; No Study Results Posted on ClinicalTrials.gov for this Study
WebSep 10, 2024 · Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc. Investigators. Principal Investigator: Yongsheng Wang, West China Hospital; Study Documents (Full … WebSichuan Baili Pharmaceutical Co., Ltd. is headquartered in China Sichuan Sheng. Sichuan Baili Pharmaceutical Co., Ltd. was founded in 1996. Sichuan Baili Pharmaceutical Co., …
WebMay 26, 2024 · SICHUAN BAILI PHARMACEUTICAL CO LTD. Country: China. Date: Priority . 2024/05/26. This web page summarizes information in PubChem about patent CN …
WebAt a glance. Originator Sichuan Baili Pharmaceutical. Developer Sichuan Baili Pharmaceutical; SystImmune. Class Antineoplastics; Immunoconjugates; Monoclonal … greek restaurant mcallen texasWebSichuan Baili Pharmaceutical Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2024-06-25 Filing date 2024-06-22 Publication date 2024-01-30 Priority claimed from US202462524557P external-priority flower delivery bessemer city ncWebAffiliations 1 Department of Pharmaceutics, School of Pharmaceutical Science, Peking University Health Science Center, Beijing 100191, China.; 2 Sichuan Baili Pharmaceutical … flower delivery bethel ctWebJan 18, 2024 · Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc. Investigators. Principal Investigator: Li Zhang, PHD, Sun Yat-sen University; Study Documents (Full-Text) … greek restaurant long branchWebMay 26, 2024 · SICHUAN BAILI PHARMACEUTICAL CO LTD. Country: China. Date: Priority . 2024/05/26. This web page summarizes information in PubChem about patent CN-111689980-A. This includes chemicals mentioned, as reported by PubChem contributors, as well as other content, such as title, abstract, and International Patent Classification (IPC) … greek restaurant mary esther flWebMar 17, 2024 · 17 Mar 2024 Sichuan Baili Pharmaceutical initiates enrolment in a phase I/II trial for Head and Neck Squamous Cell Carcinoma in China (NCT05668858) 31 Dec 2024 … greek restaurant malvern eastWebDec 16, 2024 · Sichuan Baili Pharmaceutical Co., Ltd. ClinicalTrials.gov Identifier: NCT05160545 Other Study ID Numbers: GNC-035-103 : First Posted: December 16, 2024 … flower delivery berri south australia